PharmaCielo Ltd.
PCLOF
$0.03
-$0.01-17.21%
OTC PK
| 06/30/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -8.51% | 8.57% | 8.57% | 2.42% |
| Total Depreciation and Amortization | -- | 204.85% | 383.02% | 544.60% | 88.68% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 19.78% | 4.77% | 0.91% | 3.45% |
| Change in Net Operating Assets | -- | 1,150.24% | 45.47% | 45.47% | 218.45% |
| Cash from Operations | -- | 43.94% | 46.42% | 46.42% | 40.54% |
| Capital Expenditure | -- | 92.70% | 98.56% | 98.56% | 99.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -83.52% | -71.83% | -71.83% | 21.59% |
| Cash from Investing | -- | -82.30% | -5.97% | -5.97% | 169.84% |
| Total Debt Issued | -- | -42.59% | -38.91% | -35.77% | -36.68% |
| Total Debt Repaid | -- | -19.44% | -16.16% | -16.16% | -47.52% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 492.50% | -100.00% | 492.50% | 492.50% |
| Cash from Financing | -- | -34.79% | -39.86% | -39.86% | -42.05% |
| Foreign Exchange rate Adjustments | -- | 149.02% | 150.34% | 150.34% | 163.64% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 100.74% | 93.07% | 93.07% | 71.39% |